The Effects of Vitamin D on Immune System and Inflammatory Diseases - Ao, Tomoka; Kikuta, Junichi; Ishii, Masaru (Biomolecules (Basel, Switzerland), 2021)
Keywords: Animals; Antibiotics; Antigens; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - prevention & control; Autoimmune diseases; Autoimmune Diseases - drug therapy; Autophagy; B-Lymphocytes - immunology; Bacteria; Coronaviruses; COVID-19; COVID-19 - drug therapy; COVID-19 - prevention & control; Cytokines; Dendritic cells; Dendritic Cells - immunology; Disease Models, Animal; Enzymes; Epidemiology; Humans; Hydroxylase; Immune system; Immune System - drug effects; Immunomodulation; Infections; Infectious diseases; Inflammation - drug therapy; Inflammatory diseases; Influenza; Influenza, Human - drug therapy; Influenza, Human - prevention & control; Lupus Erythematosus, Systemic - drug therapy; Lupus Erythematosus, Systemic - prevention & control; Lymphocytes; Lymphocytes B; Macrophages; Macrophages - immunology; Mice; Monocytes - immunology; Morbidity; Multiple sclerosis; multiple sclerosis (MS); Multiple Sclerosis - drug therapy; Multiple Sclerosis - prevention & control; Pathogens; Peptides; Public health; Receptors, Calcitriol - genetics; Receptors, Calcitriol - physiology; Review; Rheumatoid arthritis; rheumatoid arthritis (RA); Severe acute respiratory syndrome coronavirus 2; Systemic lupus erythematosus; systemic lupus erythematosus (SLE); T-Lymphocytes - immunology; Transcription factors; Vitamin D; Vitamin D - therapeutic use; Vitamin D Deficiency - complications; Vitamin deficiency; COVID-19; multiple sclerosis (MS); immune system; rheumatoid arthritis (RA); systemic lupus erythematosus (SLE); vitamin D